Table 3.
Impact of LPS-Induced Preterm Birth in Adult C57bl/6 Mice with a History of Developmental TCDD Exposure
Mouse Phenotype and Treatment | Pregnancy Rate | Pregnancy Outcome | |
---|---|---|---|
Full-Term | Preterm | ||
Vehicle Control + 200 uL PBS1 | |||
conF1 | 7/7 (100%) | 7/7 | 0/7 |
Vehicle Control + 200 ug/kg LPS2 | |||
conF1 | 5/5 (100%) | 5/5 | 0/5 |
TCDD in utero + 200 ug/kg LPS3 | |||
F1 | 3/6 (50%) | 0/3 | 3/3 |
Pregnant, control mice (conF1) were provided 200 uL PBS by intraperitoneal injection under anesthesia on E16.5 and monitored until delivery.
Pregnant, control mice (conF1) were provided 200 mg/kg LPS in 200 uL PBS by intraperitoneal injection under anesthesia on E16.5 and monitored until delivery.
Pregnant, adult mice which were exposed to TCDD during their own in utero development (F1), were provided 200 mg/kg LPS in 200 uL PBS by intraperitoneal injection under anesthesia on E16.5 and monitored until delivery.